+966 568813716 [email protected]

Drugs

Home / Archive by category "Drugs"
26
Dec
2021
Erectile dysfunction: Unusual solutions
Posted On December 26, 2021  By Dr.Adel Serag  And has No Comment

Here is a look at some alternative therapies that may be more effective and tolerable, and some devices that can offer much-needed support. Injection therapy The thought of injecting drugs into your penis with a needle may make you squeamish, but this approach can get medication […]

Read More

10
Dec
2021
Faverin : أقراص الفافرين أو الفلوفوكساين
Posted On December 10, 2021  By Dr.Adel Serag  And has No Comment

Brands Faverin , Luvox, Luvox CR, others   Approved for Obsessive-compulsive disorder (OCD), ages 8 and older (fluvoxamine and fluvoxamine CR) Social anxiety disorder (fluvoxamine CR)   Mechanism of Action Fluvoxamine presumably increases serotonergic neurotransmission by blocking the serotonin reuptake pump (transporter), which results in desensitization […]

Read More

07
Aug
2019
Epinephrine (Adrenaline)
Posted On August 7, 2019  By Dr.Adel Serag  And has No Comment

Adrenalin® (epinephrine injection, USP) is a clear, colorless, sterile solution containing 1 mg/mL (1:1000) epinephrine, packaged as 1 mL of solution in a single-use clear glass vial or 30 mL of solution in a multiple-dose amber glass vial. In the 1 mL vial, each 1 mL of […]

Read More

01
Sep
2018
FDA approved psychoactive medication for Children
Posted On September 1, 2018  By Dr.Adel Serag  And has No Comment

Fluoxetine for Pediatric Patients US FDA Approved for Pediatric Use Major depressive disorder (fluoxetine, ages 8 and older) Obsessive compulsive disorder (fluoxetine, ages 7 and older) Bipolar depression [in combination with olanzapine (Symbyax), ages 10 and older] Off-Label for Pediatric Use But Approved in Adults Panic […]

Read More

14
Jul
2018
TOPIRAMATE
Posted On July 14, 2018  By Dr.Adel Serag  And has No Comment

Topiramate What’s of Interest: In 2014, Topamax (topiramate) became the first medication approved to prevent migraine headaches in adolescents (ages 12 to 17) Brands Topamax, others Class Anticonvulsant, voltage-sensitive sodium channel modulator Approved For: Migraine prophylaxis (ages 12 and older)  Other indications include partial onset seizures, […]

Read More

14
Jul
2018
OLANZAPINE
Posted On July 14, 2018  By Dr.Adel Serag  And has No Comment

Olanzapine What’s of Interest: US FDA warned that olanzapine is associated with a rare but serious skin condition known as Drug Reaction with Eosinophilia (DRESS). DRESS may begin as a rash but can progress to others parts of the body and can include symptoms such as […]

Read More

14
Jul
2018
CLOZAPINE
Posted On July 14, 2018  By Dr.Adel Serag  And has No Comment

Clozapine What’s of Interest: Clozapine REMS and ANC monitoring update Brands Clozaril, Leponex, Versacloz (oral suspension), Fazaclo ODT (oral disintegrating tablet) Class Atypical antipsychotic (serotonin-dopamine antagonist; second-generation antipsychotic; also a mood stabilizer) Approved For: Treatment-resistant schizophrenia   Reduction in risk of recurrent suicidal behavior in patients […]

Read More

11
Jul
2018
Lurasidone : Latuda
Posted On July 11, 2018  By Dr.Adel Serag  And has No Comment

What’s of Interest: Latuda is now approved for pediatric bipolar depression (ages 10 and older) Brands Latuda Class Atypical antipsychotic (serotonin-dopamine antagonist; second generation antipsychotic; also a mood stabilizer) Approved For: Schizophrenia (ages 13 and older) Bipolar depression (ages 10 and older, monotherapy) Bipolar depression (adults, […]

Read More

02
Jun
2018
May 21, 2018   :FDA Approves First Non-Opioid to Treat Opioid Withdrawal Symptoms 
Posted On June 2, 2018  By Dr.Adel Serag  And has No Comment

    The US FDA has approved the first non-opioid treatment for the relief of opioid withdrawal symptoms. The medication, lofexidine hydrochloride (trade name Lucemyra), is an oral, selective alpha-2 adrenergic receptor agonist that reduces the release of norepinephrine, which may lead to relief of autonomic […]

Read More

27
Jan
2017
Comparison Synthetic Vs Non Synthetic Cannabinoids
Posted On January 27, 2017  By Dr.Adel Serag  And has No Comment

Prof. Dr. Tarek Assad sums up the difference between synthetic and natural cannabinoids. Aspects of comparison are regarding nature, pharmacology, morbidity …etc. The data were explained within a weekly scientific meeting in the Institute of Psychiatry, Ain Shams University, Jan 17-2017

Read More